Providing the right information upfront may ease new requirements to assess solvent levels.
Susan J. Schniepp
Advertisement
Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.
Articles by Susan J. Schniepp
The authors dispel common misinterpretations of the United States Pharmacopeia.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
4
PharmTech Weekly Roundup—July 17, 2026
5